Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Calcified Tissue International
Published in: Calcified Tissue International 2/2013

01-02-2013 | Original Research

What Is Vitamin D Insufficiency? And Does It Matter?

Author: Robert P. Heaney

Published in: Calcified Tissue International | Issue 2/2013

Login to get access

Abstract

The term nutrient “insufficiency,” as commonly used, refers to a nutritional status intermediate between classical, severe deficiency, and full normal. As both “deficiency” and “insufficiency” are causes of dysfunction and disease, there is no biological basis for a distinction between them. What is important to note is that, in the case of vitamin D, the preponderance of the evidence indicates that there is real, preventable disease in the range of vitamin D status values now labeled “insufficient.”
Literature
1.
McCollum EV (1918) The “vitamin” hypothesis and the diseases referable to faulty diets. JAMA 71:937–940CrossRef
2.
3.
Heaney RP, Roller S (2012) Nutrition, health policy, and the problem of proof. In: Coulston AM, Boushey CJ, Feerruzzi M (eds) Nutrition in the prevention and treatment of disease, 3rd edn. Elsevier, San Diego
4.
Blumberg J, Heaney RP, Huncharek M, Scholl T, Stampfer M, Vieth R, Weaver CM, Zeisel SH (2010) Evidence-based criteria in the nutritional context. [Appendix: Amplification on certain of the points discussed in the paper (online only).] Nutr Rev 68:478–484
5.
Heaney RP, Weaver CM, Blumberg J (2011) EBN (evidence-based nutrition) ver. 2.0. Nutr Today 46:22–26CrossRef
6.
Heaney RP (2008) 2008 W.O. Atwater Memorial Lecture. Nutrients, endpoints, and the problem of proof. J Nutr 138:1591–1595PubMed
7.
Willett WC (2010) The WHI joints MRFIT: a revealing look beneath the covers. Am J Clin Nutr 91:829–830PubMedCrossRef
8.
Priemel M, von Domarus C, Klatte TO, Kessler S, Schlie J, Meier S, Proksch N, Pastor F, Netter C, Streichert T, Puschel K, Amling M (2010) Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. J Bone Miner Res 25:305–312PubMedCrossRef
9.
10.
IOM (Institute of Medicine) (2011) Dietary reference intakes for calcium and vitamin D. National Academies Press, Washington, DC
11.
12.
Aloia JF, Talwar SA, Pollack S, Feuerman M, Yeh JK (2006) Optimal vitamin D status and serum parathyroid hormone concentrations in African American women. Am J Clin Nutr 84:602–609PubMed
13.
Kinyamu HK, Gallagher JC, Balhorn KE, Petranick KM, Rafferty KA (1997) Serum vitamin D metabolites and calcium absorption in normal young and elderly free-living women and in women living in nursing homes. Am J Clin Nutr 67:342–348
14.
Webb AR (2006) Who, what, where and when—influences on cutaneous vitamin D synthesis. Prog Biophys Mol Biol 92:17–25PubMedCrossRef
15.
Holick MF (1985) The photobiology of vitamin D and its consequences for humans. Ann N Y Acad Sci 453:1–13PubMedCrossRef
16.
Webb AR, Kline L, Holick MF (1988) Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab 67:373–378PubMedCrossRef
17.
Holick MF, Matsuoka LY, Wortsman J (1989) Age, vitamin D, and solar ultraviolet. Lancet 2:1104–1105PubMedCrossRef
18.
Hall LM, Kimlin MG, Aronov PA, Hammock BD, Slusser JR, Woodhouse LR, Stephensen CB (2010) Vitamin D intake needed to maintain target serum 25-hydroxyvitamin D concentrations in participants with low sun exposure and dark skin pigmentation is substantially higher than current recommendations. J Nutr 140:542–550PubMedCrossRef
19.
Armas LAG, Dowell MS, Akhter M, Duthuluru S, Huerter C, Hollis BW, Lund R, Heaney RP (2007) Ultraviolet-B radiation increases serum 25-hydroxyvitamin D levels: the effect of UV-B dose and skin color. J Am Acad Dermatol 57:588–593PubMedCrossRef
20.
Barger-Lux MJ, Heaney RP (2002) Effects of above average summer sun exposure on serum 25-hydroxyvitamin D and calcium absorption. J Clin Endocrinol Metab 87:4952–4956PubMedCrossRef
21.
Vieth R (1999) Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 69:842–856PubMed
22.
Luxwolda ME, Kuipers RS, Kema IP, Dijck-Brouwer DAJ, Muskiet FAJ (2012) Traditionally living populations in East Africa have a mean serum 25-hydroxyvitamin D concentration of 115 nmol/L. Br J Nutr. doi:10.​1017/​S000711451100716​1
23.
Holick MF, Chen TC (2008) Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 87(Suppl):1080S–1086SPubMed
24.
25.
Holick MF (2006) High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 81:353–373PubMedCrossRef
26.
Peterlik M, Cross HS (2005) Vitamin D and calcium deficits predispose for multiple chronic diseases. Eur J Clin Invest 35:290–304PubMedCrossRef
27.
Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich, Dawson-Hughes B (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84:18–28PubMed
28.
Boucher BJ (2011) The 2010 recommendations of the American Institute of Medicine for daily intakes of vitamin D. Public Health Nutr 14:740PubMedCrossRef
29.
Giovannucci E (2011) Vitamin D, how much is enough and how much is too much? Public Health Nutr 14:740–741PubMedCrossRef
30.
Gorham ED, Garland CF (2011) Vitamin D and the limits of randomized controlled trials. Public Health Nutr 14:741–743PubMedCrossRef
31.
32.
33.
Grant WB (2011) The Institute of Medicine did not find the vitamin D–cancer link because it ignores UV-B dose studies. Public Health Nutr 14:745–746PubMedCrossRef
34.
Schwalfenberg GK, Whiting SJ (2011) A Canadian response to the 2010 Institute of Medicine vitamin D and calcium guidelines. Public Health Nutr 14:746–748PubMedCrossRef
35.
Hollis BW, Wagner CL (2011) The vitamin D requirement during human lactation: the facts and IOM’s “utter” failure. Public Health Nutr 14:748–749PubMedCrossRef
36.
37.
Holick MF (2011) The D-batable Institute of Medicine report: a D-lightful perspective. Endocr Prac 7:143–149
38.
Heaney RP, Holick MF (2011) Why the IOM recommendations for vitamin D are deficient. J Bone Miner Res 26:455–467PubMedCrossRef
39.
Recker RR, Kimmel DB, Parfitt AM, Davies KM, Keshawarz N, Hinders S (1988) Static and tetracycline-based bone histomorphometric data from 34 normal postmenopausal females. J Bone Miner Res 3:133–144PubMedCrossRef
40.
Trivedi DP, Doll R, Khaw T (2003) Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomized double blind controlled trial. BMJ 326:469–474PubMedCrossRef
41.
Bischoff-Ferrari HA, Willett WC, Wong JB, Stuck AE, Staehelin HB, Orav J, Thoma A, Kiel DP, Henschkowski J (2009) Prevention of nonvertebral fractures with oral vitamin D and dose dependency. Arch Intern Med 169:551–561PubMedCrossRef
42.
Bischoff-Ferrari HA, Willet WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B (2005) Fracture prevention with vitamin D supplementation. JAMA 293:2257–2264PubMedCrossRef
43.
Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck AE, Theiler R, Wong JB, Egli A, Kiel DP, Henschkowski J (2009) Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomized controlled trials. BMJ 339:b3692PubMedCrossRef
44.
Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, Ida H (2010) Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr 91:1255–1260PubMedCrossRef
45.
Bischoff-Ferrari HA, Dawson-Hughes B, Stöcklin E, Sidelnikov E, Willett WC, Orav EJ, Stähelin HB, Wolfram S, Jetter A, Schwager J, Henschkowski J, von Eckardstein A, Egli A (2012) Oral supplementation with 25(OH)D3 versus vitamin D3: effects on 25(OH)D levels, lower extremity function, blood pressure, and markers of innate immunity. J Bone Miner Res 27:160–169CrossRef
46.
Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP (2007) Vitamin D and calcium supplementation reduces cancer risk. Am J Clin Nutr 85:1586–1591PubMed
47.
Pfeifer M, Begerow B, Minne HW, Nachtigall D, Hansen C (2001) Effects of a short-term vitamin D3 and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab 86:1633–1637PubMedCrossRef
48.
Brooke OG, Brown IRF, Bone CDM, Carter ND, Cleeve HJW, Maxwell JD, Robinson VP, Winder SM (1980) Vitamin D supplements in pregnant Asian women: effects on calcium status and fetal growth. BMJ 15:751–754CrossRef
49.
Nursyam EW, Amin Z, Rumende CM (2006) The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med Indones 38:3–5PubMed
50.
Prince RL, Austin N, Devine A, Dick IM, Bruce D, Zhu K (2008) Effects of ergocalciferol added to calcium on the risk of falls in elderly high-risk women. Arch Intern Med 168:103–108PubMedCrossRef
51.
Krause R, Bühring M, Hopfenmüller W, Holick MF, Sharma AM (1998) Ultraviolet-B and blood pressure. Lancet 352:709–710PubMedCrossRef
52.
Sanders KM, Stuart AL, Williamson EJ, Simpson JA, Kotowicz MA, Young D, Nicholson GC (2010) Annual high-dose oral vitamin D and falls and fractures in older women. JAMA 303:1815–1822PubMedCrossRef
53.
Smith H, Anderson F, Raphael H, Maslin P, Crozier S, Cooper C (2007) Effect of annual intramuscular vitamin D on fracture risk in elderly men and women—a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology 46:1852–1857PubMedCrossRef
54.
Vieth R (2009) How to optimize vitamin D supplementation to prevent cancer, based on cellular adaptation and hydroxylase enzymology. Anticancer Res 29:3675–3684PubMed
55.
Heaney RP, Rafferty K (2008) The preponderance of the evidence: an example from the issue of calcium intake and body composition. Nutr Rev 67:32–39CrossRef
Metadata
Title
What Is Vitamin D Insufficiency? And Does It Matter?
Author
Robert P. Heaney
Publication date
01-02-2013
Publisher
Springer-Verlag
Published in
Calcified Tissue International / Issue 2/2013
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-012-9605-6

Other articles of this Issue 2/2013

Calcified Tissue International 2/2013 Go to the issue

Original Research

Vitamin D and Bone Health in Childhood and Adolescence

Original Research

Physiological Insights from the Vitamin D Receptor Knockout Mouse

Review

Genetic Regulation of Vitamin D Levels

Original Research

Casting New Light on the Sunshine Vitamin

Original Research

Is High Dose Vitamin D Harmful?

Original Research

What is the Optimal Dietary Intake of Vitamin D for Reducing Fracture Risk?
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits